,
Gastrointestinal and neurologic symptoms, especially nausea, vomiting, and abdominal pain, became more frequent, while hypoglycemia reports declined
in-use pens at room temperature for up to 56 days Key trial / SUSTAIN-7 showed 5.5 to 7.3 kg weight loss at 1 mg over 40 weeks in type 2 diabetes patients Titration schedule / start at 0.25 mg for 4 weeks, then increase to 0.5 mg
Were committed to offering insights, guidance, and treatments that cater to your specific needs
Furthermore, the highly competitive landscape means that only a handful of companies may capture substantial market share, while others might face pricing pressures and market fragmentation
the Department of General Internal Medicine 3, Kawasaki Medical School, Okayama, Japan (H.I.)